Top Markets
#1 TENDIES TENDIES +43.38%
#2 Cash Cat Cash Cat +27.85%
#3 ICON ICON +27.68%
#4 Threshold Network Threshold Network +17.98%
#5 OSK OSK +15.90%
#6 Asteroid Shiba Asteroid Shiba +12.87%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 Magma Finance Magma Finance +11.96%
#9 MarsCoin MarsCoin +11.06%
#10 Kite Kite +10.88%
Coin of the day
TENDIES TENDIES
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Clasificación en acciones #16898
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Precio por acción
$2.46
Capitalización bursátil
$268.65M
Cambio (1 día)
-1.73%
Cambio (1 año)
-57.06%
País
CN
Comercio VISEN Pharmaceuticals (2561)

Categoría

Healthcare
Precio 2561 con Capital del mercado a B
VISEN Pharmaceuticals VISEN Pharmaceuticals
2561
$2.46
Capitalización de mercado de VISEN Pharmaceuticals(2561)
Capitalización bursátil: $268.65M
A fecha de September 2026, VISEN Pharmaceuticals tiene una capitalización de mercado de $268.65M. Esto convierte a VISEN Pharmaceuticals en la 16898th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de VISEN Pharmaceuticals desde 2025 hasta 2026
2561 en comparación con los más populares 5 títulos stocks
Precio por 2561 Activo B Capital del mercado en B Resultados
VISEN Pharmaceuticals VISEN Pharmaceuticals
$48,237.65 $268.65M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +1,957,708.65%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$43,825.52 $268.65M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,778,634.69%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$36,838.88 $268.65M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,495,069.96%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$34,111.04 $268.65M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,384,355.66%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$25,076.63 $268.65M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +1,017,678.60%